Global PCOS Treatment Market, By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others), By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics), By Region, Forecast & Opportunities, 2025

January 2021 | 114 pages | ID: G48E28FC7612EN
TechSci Research

Abstracts

Global PCOS treatment market valued around USD 3.39 Billion in 2019 and is expected to grow at a formidable rate of around 8.63% during the forecast period. The global PCOS treatment market is driven by the increasing prevalence of diabetes and obesity among the woman population. Additionally, increasing cases of hormonal imbalances in the women are further expected to propel the market during forecast period. Furthermore, the development of new drugs and treatment options for the treatment of PCOS is expected to fuel the growth of market through 2025.

The global PCOS treatment market is segmented based on surgery, drug, diagnosis, end user, company and region. Based on surgery, the market can be categorized into ovarian wedge resection, cyst aspiration and laparoscopic ovarian drilling. The laparoscopic ovarian drilling segment is expected to dominate the market during forecast years. This can be attributed to the fertility problems faced by the women due to this problem and the response to medications generally weakens over time in women. Additionally, this procedure is cost effective and easy to perform which is driving the growth of segment across the globe.

Regionally, the global PCOS treatment market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to dominate the global PCOS treatment market owing to the growing prevalence of overweight and obese women population in the region.

Major players operating in the global PCOS treatment market include Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Inc., Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:

• To analyze and estimate the market size of global PCOS treatment market from 2015 to 2018.
• To estimate and forecast the market size of global PCOS treatment market from 2019 to 2025 and growth rate until 2025.
• To classify and forecast global PCOS treatment market based on treatment, diagnosis, end user, company and regional distribution.
• To identify dominant region or segment in the global PCOS treatment market.
• To identify drivers and challenges for global PCOS treatment market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global PCOS treatment market.
• To identify and analyze the profile of leading players operating in global PCOS treatment market.
• To identify key sustainable strategies adopted by market players in global PCOS treatment market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals & clinics, ambulatory surgical centers, fertility clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals & clinics, ambulatory surgical centers, fertility clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals & clinics, ambulatory surgical centers, fertility clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global PCOS treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• PCOS treatment hospitals & clinics, ambulatory surgical centers, fertility centers and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to PCOS treatment
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals & clinics, ambulatory surgery centers, fertility clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global PCOS treatment market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Global PCOS Treatment Market, By Surgery:
• Laparoscopic Ovarian Drilling
• Cyst Aspiration
• Ovarian Wedge Resection
• Global PCOS Treatment Market, By Drug:
• Ovulation Inducing Agents
• Insulin-Sensitizing Agents
• Oral Contraceptives
• Antiandrogens
• Anti-Obesity Drugs
• Anti-Depressants
• Others
• Global PCOS Treatment Market, By Diagnosis:
• Pelvic Examination
• Ultrasound
• Blood Tests
• Global PCOS Treatment Market, By End User:
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Fertility Clinics
• Global PCOS Treatment Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• South America
• Brazil
• Argentina
• Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global PCOS treatment market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL PCOS TREATMENT MARKET

4. EXECUTIVE SUMMARY

5. VOICE OF CUSTOMER

6. GLOBAL PCOS TREATMENT MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling)
  6.2.2. By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others)
  6.2.3. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)
  6.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)
  6.2.5. By Company (2019)
  6.2.6. By Region
6.3. Product Market Map

7. ASIA-PACIFIC PCOS TREATMENT MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Surgery
  7.2.2. By Drug
  7.2.3. By Diagnosis
  7.2.4. By End User
  7.2.5. By Country
7.3. Asia-Pacific: Country Analysis
  7.3.1. China PCOS Treatment Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Surgery
      7.3.1.2.2. By Drug
      7.3.1.2.3. By Diagnosis
      7.3.1.2.4. By End User
  7.3.2. India PCOS Treatment Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Surgery
      7.3.2.2.2. By Drug
      7.3.2.2.3. By Diagnosis
      7.3.2.2.4. By End User
  7.3.3. Australia PCOS Treatment Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Surgery
      7.3.3.2.2. By Drug
      7.3.3.2.3. By Diagnosis
      7.3.3.2.4. By End User
  7.3.4. Japan PCOS Treatment Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Surgery
      7.3.4.2.2. By Drug
      7.3.4.2.3. By Diagnosis
      7.3.4.2.4. By End User
  7.3.5. South Korea PCOS Treatment Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Surgery
      7.3.5.2.2. By Drug
      7.3.5.2.3. By Diagnosis
      7.3.5.2.4. By End User

8. EUROPE PCOS TREATMENT MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Surgery
  8.2.2. By Drug
  8.2.3. By Diagnosis
  8.2.4. By End User
  8.2.5. By Country
8.3. Europe: Country Analysis
  8.3.1. France PCOS Treatment Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Surgery
      8.3.1.2.2. By Drug
      8.3.1.2.3. By Diagnosis
      8.3.1.2.4. By End User
  8.3.2. Germany PCOS Treatment Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Surgery
      8.3.2.2.2. By Drug
      8.3.2.2.3. By Diagnosis
      8.3.2.2.4. By End User
  8.3.3. United Kingdom PCOS Treatment Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Surgery
      8.3.3.2.2. By Drug
      8.3.3.2.3. By Diagnosis
      8.3.3.2.4. By End User
  8.3.4. Italy PCOS Treatment Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Surgery
      8.3.4.2.2. By Drug
      8.3.4.2.3. By Diagnosis
      8.3.4.2.4. By End User
  8.3.5. Spain PCOS Treatment Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Surgery
      8.3.5.2.2. By Drug
      8.3.5.2.3. By Diagnosis
      8.3.5.2.4. By End User

9. NORTH AMERICA PCOS TREATMENT MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Surgery
  9.2.2. By Drug
  9.2.3. By Diagnosis
  9.2.4. By End User
  9.2.5. By Country
9.3. North America: Country Analysis
  9.3.1. United States PCOS Treatment Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Surgery
      9.3.1.2.2. By Drug
      9.3.1.2.3. By Diagnosis
      9.3.1.2.4. By End User
  9.3.2. Mexico PCOS Treatment Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Surgery
      9.3.2.2.2. By Drug
      9.3.2.2.3. By Diagnosis
      9.3.2.2.4. By End User
  9.3.3. Canada PCOS Treatment Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Surgery
      9.3.3.2.2. By Drug
      9.3.3.2.3. By Diagnosis
      9.3.3.2.4. By End User

10. SOUTH AMERICA PCOS TREATMENT MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Surgery
  10.2.2. By Drug
  10.2.3. By Diagnosis
  10.2.4. By End User
  10.2.5. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil PCOS Treatment Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Surgery
      10.3.1.2.2. By Drug
      10.3.1.2.3. By Diagnosis
      10.3.1.2.4. By End User
  10.3.2. Argentina PCOS Treatment Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Surgery
      10.3.2.2.2. By Drug
      10.3.2.2.3. By Diagnosis
      10.3.2.2.4. By End User
  10.3.3. Colombia PCOS Treatment Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Surgery
      10.3.3.2.2. By Drug
      10.3.3.2.3. By Diagnosis
      10.3.3.2.4. By End User

11. MIDDLE EAST AND AFRICA PCOS TREATMENT MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Surgery
  11.2.2. By Drug
  11.2.3. By Diagnosis
  11.2.4. By End User
  11.2.5. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa PCOS Treatment Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Surgery
      11.3.1.2.2. By Drug
      11.3.1.2.3. By Diagnosis
      11.3.1.2.4. By End User
  11.3.2. Saudi Arabia PCOS Treatment Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Surgery
      11.3.2.2.2. By Drug
      11.3.2.2.3. By Diagnosis
      11.3.2.2.4. By End User
  11.3.3. UAE PCOS Treatment Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Surgery
      11.3.3.2.2. By Drug
      11.3.3.2.3. By Diagnosis
      11.3.3.2.4. By End User

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMMONLY USED PCOS DRUGS TO CONTROL DIFFERENT SYMPTOMS

15. COMPETITIVE LANDSCAPE

15.1. Bristol-Myers Squibb Company
15.2. Bayer AG
15.3. Pfizer, Inc.
15.4. Abbott Laboratories, Inc.
15.5. Merck & Co., Inc.
15.6. Sanofi SA
15.7. AstraZeneca Plc
15.8. Novartis AG
15.9. Teva Pharmaceutical Industries Limited
15.10. Ferring Pharmaceuticals, Inc.

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER

List Of Tables

LIST OF TABLES

1. TABLE 1: DRUGS USED FOR CONTROLLING VARIOUS SYMPTOMS OF PCOS

List Of Figures

LIST OF FIGURES

1. GLOBAL PCOS TREATMENT MARKET, BY VALUE, 2015-2025

2. GLOBAL PCOS TREATMENT MARKET SHARE, BY SURGERY, BY VALUE, 2015-2025

3. GLOBAL PCOS TREATMENT MARKET SHARE, BY DRUG, BY VALUE, 2015-2025

4. GLOBAL PCOS TREATMENT MARKET SHARE, BY DIAGNOSIS, BY VALUE, 2015-2025

5. GLOBAL PCOS TREATMENT MARKET SHARE, BY END USER, BY VALUE, 2015-2025

6. GLOBAL PCOS TREATMENT MARKET SHARE, BY COMPANY, BY VALUE, 2015-2025

7. GLOBAL PCOS TREATMENT MARKET SHARE, BY REGION, BY VALUE, 2015-2025

8. NORTH AMERICA PCOS TREATMENT MARKET, BY VALUE, 2015-2025

9. NORTH AMERICA PCOS TREATMENT MARKET SHARE, BY SURGERY, BY VALUE, 2015-2025

10. NORTH AMERICA PCOS TREATMENT MARKET SHARE, BY DRUG, BY VALUE, 2015-2025

11. NORTH AMERICA PCOS TREATMENT MARKET SHARE, BY DIAGNOSIS, BY VALUE, 2015-2025

12. NORTH AMERICA PCOS TREATMENT MARKET SHARE, BY END USER, BY VALUE, 2015-2025

13. NORTH AMERICA PCOS TREATMENT MARKET SHARE, BY COUNTRY, BY VALUE, 2015-2025

14. EUROPE PCOS TREATMENT MARKET, BY VALUE, 2015-2025

15. EUROPE PCOS TREATMENT MARKET SHARE, BY SURGERY, BY VALUE, 2015-2025

16. EUROPE PCOS TREATMENT MARKET SHARE, BY DRUG, BY VALUE, 2015-2025

17. EUROPE PCOS TREATMENT MARKET SHARE, BY DIAGNOSIS, BY VALUE, 2015-2025

18. EUROPE PCOS TREATMENT MARKET SHARE, BY END USER, BY VALUE, 2015-2025

19. EUROPE PCOS TREATMENT MARKET SHARE, BY COUNTRY, BY VALUE, 2015-2025

20. ASIA PACIFIC PCOS TREATMENT MARKET, BY VALUE, 2015-2025

21. ASIA PACIFIC PCOS TREATMENT MARKET SHARE, BY SURGERY, BY VALUE, 2015-2025

22. ASIA PACIFIC PCOS TREATMENT MARKET SHARE, BY DRUG, BY VALUE, 2015-2025

23. ASIA PACIFIC PCOS TREATMENT MARKET SHARE, BY DIAGNOSIS, BY VALUE, 2015-2025

24. ASIA PACIFIC PCOS TREATMENT MARKET SHARE, BY END USER, BY VALUE, 2015-2025

25. ASIA PACIFIC PCOS TREATMENT MARKET SHARE, BY COUNTRY, BY VALUE, 2015-2025

26. MEA PCOS TREATMENT MARKET, BY VALUE, 2015-2025

27. MEA PCOS TREATMENT MARKET SHARE, BY SURGERY, BY VALUE, 2015-2025

28. MEA PCOS TREATMENT MARKET SHARE, BY DRUG, BY VALUE, 2015-2025

29. MEA PCOS TREATMENT MARKET SHARE, BY DIAGNOSIS, BY VALUE, 2015-2025

30. MEA PCOS TREATMENT MARKET SHARE, BY END USER, BY VALUE, 2015-2025

31. MEA PCOS TREATMENT MARKET SHARE, BY COUNTRY, BY VALUE, 2015-2025

32. SOUTH AMERICA PCOS TREATMENT MARKET, BY VALUE, 2015-2025

33. SOUTH AMERICA PCOS TREATMENT MARKET SHARE, BY SURGERY, BY VALUE, 2015-2025

34. SOUTH AMERICA PCOS TREATMENT MARKET SHARE, BY DRUG, BY VALUE, 2015-2025

35. SOUTH AMERICA PCOS TREATMENT MARKET SHARE, BY DIAGNOSIS, BY VALUE, 2015-2025

36. SOUTH AMERICA PCOS TREATMENT MARKET SHARE, BY END USER, BY VALUE, 2015-2025

37. SOUTH AMERICA PCOS TREATMENT MARKET SHARE, BY COUNTRY, BY VALUE, 2015-2025

COMPANIES MENTIONED
1.Bristol-Myers Squibb Company
2.Bayer AG
3.Pfizer, Inc.
4.Abbott Laboratories, Inc.
5.Merck & Co., Inc.
6.Sanofi SA
7.AstraZeneca Plc
8.Novartis AG
9.Teva Pharmaceutical Industries Limited
10.Ferring Pharmaceuticals, Inc.